Please use this identifier to cite or link to this item:
https://doi.org/10.1111/pace.14486
| Title: | Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech) | Authors: | Lin, Weiqin Yip, Alfred Chung Lum Evangelista, Lauren Kay Mance Wong, Raymond Ching Chiew Tan, Huay Cheem Lim, Toon Wei Singh, Devinder |
Keywords: | Science & Technology Life Sciences & Biomedicine Technology Cardiac & Cardiovascular Systems Engineering, Biomedical Cardiovascular System & Cardiology Engineering acute myocarditis COVID-19 mRNA vaccine ventricular tachycardiac |
Issue Date: | 4-Apr-2022 | Publisher: | WILEY | Citation: | Lin, Weiqin, Yip, Alfred Chung Lum, Evangelista, Lauren Kay Mance, Wong, Raymond Ching Chiew, Tan, Huay Cheem, Lim, Toon Wei, Singh, Devinder (2022-04-04). Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech). PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. ScholarBank@NUS Repository. https://doi.org/10.1111/pace.14486 | Abstract: | To combat the coronavirus disease 2019 (COVID-19) pandemic, many countries have started population vaccination programs using messenger ribonucleic acid (mRNA) vaccines. With the widespread use of such vaccines, reports are emerging worldwide, of the vaccine's association with the development of myocarditis. Younger men are more likely to develop postvaccine myocarditis, which usually presents as self-limiting chest pain within a week after the second dose. We present a case of myocarditis following vaccination with tozinameran (BNT162b2, Pfizer-BioNTech), which presented late, with ventricular tachycardia (VT) reduced left ventricular ejection fraction (LVEF). | Source Title: | PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | URI: | https://scholarbank.nus.edu.sg/handle/10635/228513 | ISSN: | 0147-8389 1540-8159 |
DOI: | 10.1111/pace.14486 |
| Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech).pdf | 1.59 MB | Adobe PDF | CLOSED | None |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.